Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases
The Editor of this journal has published this Expression of Concern to alert readers that, following publication of the article [1], it came to light that there were undeclared competing interests that have a direct impact on the article and the strength of its findings. In addition, post publicatio...
Main Authors: | Hanan Polansky, Edan Itzkovitz, Adrian Javaherian |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-02-01
|
Series: | Clinical and Translational Medicine |
Online Access: | http://link.springer.com/article/10.1186/s40169-019-0222-0 |
Similar Items
-
Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases
by: Hanan Polansky, et al.
Published: (2016-10-01) -
Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes
by: Hanan Polansky PhD, et al.
Published: (2018-10-01) -
Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir
by: Polansky H, et al.
Published: (2016-08-01) -
Human papillomavirus (HPV): systemic treatment with Gene-Eden-VIR/Novirin safely and effectively clears virus
by: Polansky H, et al.
Published: (2017-03-01) -
Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19
by: Hanan Polansky PhD, et al.
Published: (2020-06-01)